Resultados de la búsqueda 51-60 of 10374 for Keloid

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

  2. Síntomas y causas - Mayo Clinic

    Descripción general. Diffuse midline glioma (DMG) is a rare type of cancerous brain tumor. It's most common in children between the ages of 5 and 10 years ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate different techniques to repair internal iliac artery aneurysms. Report short and long term clinical outcomes with ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    This resource-platform will be named Project BTTRFLY (Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young). Minnesota Spinal Cord Injury ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the impact of a recently developed artificial intelligence virtual assistant (AIVA) on plastic surgery patients ...

  6. Burkitt lymphoma

    In Burkitt lymphoma, changes happen that turn the B lymphocytes into cancer cells. The cancer cells can grow in the lymph nodes, jaw or other bones in the face, ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This study is designed to: -analyze effects of surgical treatment -improve surgical care and quality of life of patients with hip problems/ ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...